# Amgen Inc. (AMGN) — Q1-2019 Earnings Results

**Report date:** 2019-04-30 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2019

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 1.02%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.56 | N/A | +2.34% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautiously optimistic outlook, emphasizing their commitment to innovation. They acknowledged some challenges but remained focused on long-term growth.

**Key quotes:**

> Management highlighted the strong performance in their key therapeutic areas.

> They expressed confidence in their pipeline but acknowledged market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock fell by 1.02%, likely due to the lack of revenue details and no guidance for the future. Investors may be cautious given the absence of specific forward-looking statements.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2019_